August 27, 2026 | AI, AI pharma, AI tools, Compliant AI, Impetus Digital, QIP, Quality improvement programs, artificial intelligence, compliance, insight gathering, medical education, pharma insights, pharma teams, pharma webinar, training programs, virtual tools
See how top-tier pharma teams use compliant AI tools and virtual QIPs to capture real-time market intelligence, confidence scores, and audience insights from live dashboards

AI sounds great in theory, but very few pharma teams know how to integrate it meaningfully into their programs without creating extra friction, compliance headaches, or overspending on tech hype. Join us for our upcoming webinar Oct 14, 22, & 27, where we move beyond the buzz to explore how agile Medical Affairs, Med Ed, and Commercial teams are leveraging practical, compliant AI tools and virtual workflows to transform passive audiences into active, high-retention collaborators.
From conversational AI peers and dynamic AI-driven presentations to virtual Quality Improvement Programs (QIPs), discover how top pharma companies are boosting knowledge retention by 4x and capturing real-time market intelligence without enterprise price tags or operational complexity. The future isn’t about adopting AI for the sake of it; it’s about choosing the right tools to elevate your engagement strategies.
Real Client Case Studies: Explore actual workflows and outcomes where top pharma brands successfully deployed AI across diverse programs.
A Showcase of Next-Gen Tools: Get a firsthand look at dynamic AI presenters, interactive avatars, virtual QIP environments, and more in action.
The Business Case & ROI: Discover how to achieve 4x higher retention and maximum impact while keeping project budgets surprisingly manageable.
Frictionless & Safe Implementation: Learn the rigorous training guardrails that guarantee pharma compliance, audit readiness, and zero open-web risk.
Creative Use Cases & Best Practices: Uncover actionable strategies and tips to integrate AI across Med Ed, Medical Affairs, and Commercial launches.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events
As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish…
Pam Cusick, Senior Vice President of Rare Patient Voice, dives into diversity, equity, and inclusion in Pharma and clinical trials; ways to enhance the patient’s voice in their treatment journey…
Jón Ingi Bergsteinsson, Co-founder & CCO at SMART-TRIAL, explores the barriers to, and benefits of, digitalization of clinical operations and trials in the MedTech industry, plus much more!
With our growing dependence on social media, Digital Opinion Leaders are becoming an increasingly important stakeholder group for Pharma teams to engage and consult. But who are these DOLs, and…
Omri Shor, Co-founder & CEO of Medisafe, explores how Pharma companies can use digital therapeutics for advancing and supporting the patient journey, how new digital health tools are driving deeper…
Earlene Biggs, VP of Market Research & Analytics at ICON, explores best practices for life science market research and actionable analytics. She also shares her tips for creating organizational wellbeing…
Aubrey de Grey, Chief Science Officer at SENS Research Foundation, discusses a range of interesting topics surrounding innovative interventions and technologies that could not just postpone, but theoretically reverse, age-related…
At Impetus Digital, we pride ourselves with being the spark behind sustained healthcare stakeholder communication, collaboration, education, and insight-synthesis. Our most popular service is online advisory boards. However, there is a myriad of…
Harry Glorikian, Author & General Partner at Scientia Ventures, dives into the current and future applications of AI and other innovative health technologies, including for personalized medicine, drug development, public…
